Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2012 1
2013 2
2014 9
2015 3
2016 1
2017 2
2018 3
2019 6
2020 5
2021 5
2022 3
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease.
Ozen A, Kasap N, Vujkovic-Cvijin I, Apps R, Cheung F, Karakoc-Aydiner E, Akkelle B, Sari S, Tutar E, Ozcay F, Uygun DK, Islek A, Akgun G, Selcuk M, Sezer OB, Zhang Y, Kutluk G, Topal E, Sayar E, Celikel C, Houwen RHJ, Bingol A, Ogulur I, Eltan SB, Snow AL, Lake C, Fantoni G, Alba C, Sellers B, Chauvin SD, Dalgard CL, Harari O, Ni YG, Wang MD, Devalaraja-Narashimha K, Subramanian P, Ergelen R, Artan R, Guner SN, Dalgic B, Tsang J, Belkaid Y, Ertem D, Baris S, Lenardo MJ. Ozen A, et al. Among authors: ergelen r. Nat Immunol. 2021 Feb;22(2):128-139. doi: 10.1038/s41590-020-00830-z. Epub 2021 Jan 4. Nat Immunol. 2021. PMID: 33398182 Free PMC article.
68Ga-PSMA PET/CT in Giant Retroperitoneal Liposarcoma.
Inanir S, Kesim S, Ergelen R, Tınay İ, Türköz HK. Inanir S, et al. Among authors: ergelen r. Clin Nucl Med. 2019 Nov;44(11):e612-e613. doi: 10.1097/RLU.0000000000002762. Clin Nucl Med. 2019. PMID: 31524684
Outcomes of Pediatric Fistulising Perianal Crohn's Disease.
S Akkelle B, K Sengul O, Volkan B, Tutar E, Ergelen R, Yardimci S, Ertem D. S Akkelle B, et al. Among authors: ergelen r. Turk J Gastroenterol. 2021 Mar;32(3):240-247. doi: 10.5152/tjg.2021.191034. Turk J Gastroenterol. 2021. PMID: 34160353 Free PMC article.
A rare case of primary rectal choriocarcinoma and review of the literature.
Telli TA, Demircan NC, Alan O, Tuylu TB, Arikan R, Ercelep O, Atıcı AE, Ergelen R, Seven IE, Babacan NA, Kaya S, Dane F, Fulden Yumuk P. Telli TA, et al. Among authors: ergelen r. J Oncol Pharm Pract. 2020 Jun;26(4):989-994. doi: 10.1177/1078155219875510. Epub 2019 Sep 23. J Oncol Pharm Pract. 2020. PMID: 31547751 Review.
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study.
Ozen A, Chongsrisawat V, Sefer AP, Kolukisa B, Jalbert JJ, Meagher KA, Brackin T, Feldman HB, Baris S, Karakoc-Aydiner E, Ergelen R, Fuss IJ, Moorman H, Suratannon N, Suphapeetiporn K, Perlee L, Harari OA, Yancopoulos GD, Lenardo MJ; Pozelimab CHAPLE Working Group. Ozen A, et al. Among authors: ergelen r. Lancet. 2024 Feb 17;403(10427):645-656. doi: 10.1016/S0140-6736(23)02358-9. Epub 2024 Jan 23. Lancet. 2024. PMID: 38278170 Clinical Trial.
Predictors for the risk and severity of post-thrombotic syndrome in vascular Behçet's disease.
Aksoy A, Colak S, Yagiz B, Coskun BN, Omma A, Yildiz Y, Sari A, Atas N, Ilgin C, Karadag Ö, Erden A, Dalkilic E, Bolca N, Ergelen R, Onur MR, Direskeneli H, Alibaz-Oner F. Aksoy A, et al. Among authors: ergelen r. J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1451-1459. doi: 10.1016/j.jvsv.2021.02.007. Epub 2021 Feb 20. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33618067
41 results